Annual CFI
$274.04 M
+$423.58 M+283.25%
31 December 2023
Summary:
Blueprint Medicines annual cash flow from investing activities is currently $274.04 million, with the most recent change of +$423.58 million (+283.25%) on 31 December 2023. During the last 3 years, it has risen by +$499.90 million (+221.33%). BPMC annual CFI is now at all-time high.BPMC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$29.95 M
+$218.24 M+115.91%
30 September 2024
Summary:
Blueprint Medicines quarterly cash flow from investing activities is currently $29.95 million, with the most recent change of +$218.24 million (+115.91%) on 30 September 2024. Over the past year, it has dropped by -$48.82 million (-61.98%). BPMC quarterly CFI is now -82.67% below its all-time high of $172.79 million, reached on 31 March 2023.BPMC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$2.44 M
+$39.54 M+94.19%
30 September 2024
Summary:
Blueprint Medicines TTM cash flow from investing activities is currently -$2.44 million, with the most recent change of +$39.54 million (+94.19%) on 30 September 2024. Over the past year, it has dropped by -$276.48 million (-100.89%). BPMC TTM CFI is now -100.89% below its all-time high of $274.04 million, reached on 31 December 2023.BPMC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BPMC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -62.0% | -100.9% |
| 3 y3 years | +221.3% | +108.6% | +98.9% |
| 5 y5 years | +1764.3% | -55.8% | +85.2% |
BPMC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +221.3% | -82.7% | +108.6% | -100.9% | +99.5% |
| 5 y | 5 years | at high | +163.1% | -82.7% | +107.0% | -100.9% | +99.5% |
| alltime | all time | at high | +163.1% | -82.7% | +107.0% | -100.9% | +99.5% |
Blueprint Medicines Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $29.95 M(-115.9%) | -$2.44 M(-94.2%) |
| June 2024 | - | -$188.29 M(-344.1%) | -$41.98 M(-123.5%) |
| Mar 2024 | - | $77.13 M(-2.1%) | $178.38 M(-34.9%) |
| Dec 2023 | $274.04 M(-283.3%) | $78.77 M(-921.7%) | $274.04 M(+93.0%) |
| Sept 2023 | - | -$9.59 M(-129.9%) | $141.99 M(+634.2%) |
| June 2023 | - | $32.07 M(-81.4%) | $19.34 M(-69.9%) |
| Mar 2023 | - | $172.79 M(-424.3%) | $64.34 M(-143.0%) |
| Dec 2022 | -$149.54 M(-33.8%) | -$53.28 M(-59.7%) | -$149.54 M(-66.3%) |
| Sept 2022 | - | -$132.24 M(-271.6%) | -$443.21 M(+114.2%) |
| June 2022 | - | $77.07 M(-287.6%) | -$206.90 M(-48.2%) |
| Mar 2022 | - | -$41.09 M(-88.2%) | -$399.15 M(+76.7%) |
| Dec 2021 | -$225.86 M(-48.0%) | -$346.95 M(-433.4%) | -$225.86 M(-595.7%) |
| Sept 2021 | - | $104.07 M(-190.4%) | $45.56 M(-109.3%) |
| June 2021 | - | -$115.18 M(-187.1%) | -$488.65 M(+35.0%) |
| Mar 2021 | - | $132.20 M(-275.0%) | -$361.91 M(-16.7%) |
| Dec 2020 | -$434.25 M(+2537.2%) | -$75.53 M(-82.4%) | -$434.25 M(+49.2%) |
| Sept 2020 | - | -$430.14 M(-3820.6%) | -$290.98 M(-236.2%) |
| June 2020 | - | $11.56 M(-80.7%) | $213.69 M(-565.4%) |
| Mar 2020 | - | $59.86 M(-11.6%) | -$45.92 M(+178.9%) |
| Dec 2019 | -$16.47 M | $67.74 M(-9.1%) | -$16.47 M(-41.1%) |
| Sept 2019 | - | $74.54 M(-130.0%) | -$27.96 M(-67.5%) |
| June 2019 | - | -$248.05 M(-377.7%) | -$85.91 M(-158.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $89.31 M(+58.8%) | $147.35 M(-191.5%) |
| Dec 2018 | -$161.09 M(+122.7%) | $56.24 M(+239.0%) | -$161.09 M(-3.8%) |
| Sept 2018 | - | $16.59 M(-212.2%) | -$167.46 M(-12.7%) |
| June 2018 | - | -$14.79 M(-93.3%) | -$191.92 M(-41.4%) |
| Mar 2018 | - | -$219.13 M(-539.4%) | -$327.26 M(+352.4%) |
| Dec 2017 | -$72.35 M(-66.9%) | $49.87 M(-733.6%) | -$72.35 M(-72.2%) |
| Sept 2017 | - | -$7.87 M(-94.8%) | -$260.51 M(-2.9%) |
| June 2017 | - | -$150.14 M(-519.5%) | -$268.25 M(+138.1%) |
| Mar 2017 | - | $35.79 M(-125.9%) | -$112.67 M(-48.5%) |
| Dec 2016 | -$218.82 M(+3499.6%) | -$138.29 M(+785.4%) | -$218.82 M(+159.8%) |
| Sept 2016 | - | -$15.62 M(-386.7%) | -$84.22 M(+21.3%) |
| June 2016 | - | $5.45 M(-107.7%) | -$69.42 M(-7.6%) |
| Mar 2016 | - | -$70.36 M(+1810.0%) | -$75.16 M(+1136.4%) |
| Dec 2015 | -$6.08 M(+768.4%) | -$3.68 M(+348.2%) | -$6.08 M(+117.6%) |
| Sept 2015 | - | -$822.00 K(+185.4%) | -$2.79 M(+29.3%) |
| June 2015 | - | -$288.00 K(-77.6%) | -$2.16 M(+14.3%) |
| Mar 2015 | - | -$1.28 M(+222.1%) | -$1.89 M(+170.1%) |
| Dec 2014 | -$700.00 K(+172.4%) | -$399.00 K(+111.1%) | -$700.00 K(+132.6%) |
| Sept 2014 | - | -$189.00 K(+950.0%) | -$301.00 K(+168.8%) |
| June 2014 | - | -$18.00 K(-80.9%) | -$112.00 K(+19.1%) |
| Mar 2014 | - | -$94.00 K | -$94.00 K |
| Dec 2013 | -$257.00 K | - | - |
FAQ
- What is Blueprint Medicines annual cash flow from investing activities?
- What is the all time high annual CFI for Blueprint Medicines?
- What is Blueprint Medicines quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Blueprint Medicines?
- What is Blueprint Medicines quarterly CFI year-on-year change?
- What is Blueprint Medicines TTM cash flow from investing activities?
- What is the all time high TTM CFI for Blueprint Medicines?
- What is Blueprint Medicines TTM CFI year-on-year change?
What is Blueprint Medicines annual cash flow from investing activities?
The current annual CFI of BPMC is $274.04 M
What is the all time high annual CFI for Blueprint Medicines?
Blueprint Medicines all-time high annual cash flow from investing activities is $274.04 M
What is Blueprint Medicines quarterly cash flow from investing activities?
The current quarterly CFI of BPMC is $29.95 M
What is the all time high quarterly CFI for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash flow from investing activities is $172.79 M
What is Blueprint Medicines quarterly CFI year-on-year change?
Over the past year, BPMC quarterly cash flow from investing activities has changed by -$48.82 M (-61.98%)
What is Blueprint Medicines TTM cash flow from investing activities?
The current TTM CFI of BPMC is -$2.44 M
What is the all time high TTM CFI for Blueprint Medicines?
Blueprint Medicines all-time high TTM cash flow from investing activities is $274.04 M
What is Blueprint Medicines TTM CFI year-on-year change?
Over the past year, BPMC TTM cash flow from investing activities has changed by -$276.48 M (-100.89%)